Goldman Sachs
EVO icon

Goldman Sachs’s Evotec EVO Stock Holding History

Goldman Sachs’s Portfolio EVO Stock Details EVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-21,390
Closed -$53.5K – 6701
2026
Q1 		$53.5K Sell
21,390
-14,425
-40% -$46.5K ﹤0.01% 6291
2025
Q4 		$110K Buy
+35,815
New +$123K ﹤0.01% 6173
2025
Q3 		– Sell
-10,054
Closed -$42.2K – 6409
2025
Q2 		$42.2K Sell
10,054
-1,814
-15% -$7.11K ﹤0.01% 5932
2025
Q1 		$39.6K Sell
11,868
-49,250
-81% -$201K ﹤0.01% 5905
2024
Q4 		$254K Buy
61,118
+3,977
+7% +$16.7K ﹤0.01% 5552
2024
Q3 		$209K Sell
57,141
-7,715
-12% -$30.6K ﹤0.01% 5442
2024
Q2 		$311K Buy
+64,856
New +$364K ﹤0.01% 5089

Other funds holding EVO

DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.31B AUM 20.77% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
FC
Fore Capital New York $338M AUM 10.07% 1-Year Est. Return

Goldman Sachs's EVO Position: Q2 2026 in Review

Goldman Sachs sold out of Evotec (EVO) in Q2 2026, closing a stake of 21,390 shares — an estimated $53.5K sold.

Goldman Sachs first reported a position in EVO in Q2 2024 and held it in 7 quarters. The position peaked at $311K in Q2 2024. 34 funds tracked by Wall St. Rank hold EVO as of Q2 2026.

  • Goldman Sachs reported no remaining Evotec position as of Q2 2026 after selling out during the quarter.
  • Goldman Sachs sold 21,390 Evotec shares in Q2 2026, an estimated $53.5K.
  • Goldman Sachs first reported a position in Evotec in Q2 2024 and held it in 7 quarters.
  • Goldman Sachs's Evotec position peaked at $311K in Q2 2024.
  • 34 funds tracked by Wall St. Rank held Evotec as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.